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Introduction: The use of performance measures at the time of discharge from acute myocardial infarction (AMI) has been embraced by 
professional societies, payors and regulators, although ‘all-or-none’ composite measures have not been widely adopted. A barrier to the use of the 
composite measures has been the paucity of information regarding their relationship with improved long-term patient outcomes after an AMI and 
the limited insight into the opportunity to improve performance.
Methods: We analyzed 2 prospective national AMI registries, PREMIER and TRIUMPH, which enrolled 6,567 AMI patients between 1/03-12/04 and 
4/05-12/08, respectively. An all-or-none composite measure was calculated by whether or not the patients received all the discharge performance 
measures (aspirin, beta blocker, ACE inhibitor/ARB, statin, smoking cessation and cardiac rehabilitation referral) for which they were eligible. To 
minimize confounding, we developed propensity scores for each of the individual performance measures and the overall composite measure. The 
association between compliance with the composite measure and 5-year mortality was assessed using proportional hazards regression models 
adjusting for the 7 propensity scores as well as the number of measures eligible.
Results: Three discharge performance measures (aspirin, beta blocker and statin) were fulfilled in more than 90% of eligible patients. The 
composite measure was fulfilled in only 2,346 patients (35.7%). Patients for whom the composite measure was satisfied had lower mortality than 
those that did not (11.7% vs. 20.0%; P <0.0001). After multivariable adjustment, compliance with the composite measure remained significantly 
associated with reduced mortality (Adjusted HR, 0.84; 95% CI, 0.71-0.99; P = 0.04).
Conclusion: Whereas most performance measures are nearing 100% compliance, an ‘all-or-none’ composite measure was fulfilled in only about a 
third of patients, and was independently associated with 5-year survival. These findings highlight an opportunity for further quality improvement and 
support efforts to use a composite of existing discharge performance measures in patients with AMI.
